Drug Testing and Analysis
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 2.6 | Q3 | 46.5% | 0.712 | Q2 | 73.4% |
| 2024 | 2.7 | Q2 | 53.8% | 0.623 | Q2 | 69.7% |
| 2023 | 2.6 | Q2 | 52.4% | 0.833 | Q1 | 81.0% |
| 2022 | 2.9 | Q2 | 51.2% | 0.704 | Q1 | 77.0% |
| 2021 | 3.2 | Q3 | 54.0% | 0.878 | Q1 | 83.6% |
| 2020 | — | — | 1.065 | Q1 | 86.7% | |
| 2019 | — | — | 0.898 | Q1 | 83.2% | |
| 2018 | — | — | 0.747 | Q1 | 76.8% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1942-7603
ISSN
1942-7611
region
Western Europe
coverage
2009-2026